Gene · 2817
Papers2,608
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,608
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neuroinflammation and glycosylation-related cerebrospinal fluid proteins for predicting functional decline in amyotrophic lateral sclerosis: a proteomic study. | Front Neurol | 2024 | 39624674 | PubTator, text mining | PubMed |
In-depth analysis of lymph node metastasis-related sialylated protein profiling and their clinical and biological significance in colorectal cancer using mass spectrometry and multi-omics technologies. | Sci Rep | 2024 | 39558044 | PubTator, text mining | PubMed |
| Extracellular glypican-1 affects tumor progression and prognosis in esophageal cancer. | Cancer Med | 2024 | 39300946 | PubTator, text mining | PubMed |
| Dimension reduction, cell clustering, and cell-cell communication inference for single-cell transcriptomics with DcjComm. | Genome Biol | 2024 | 39252099 | PubTator, text mining | PubMed |
| IRTIDP: A simple integrated real-time isolation and detection platform for small extracellular vesicles Glypican-1 in pancreatic cancer patients. | Talanta | 2024 | 39191106 | PubTator, text mining | PubMed |
| Extracellular vesicles as the next-generation modulators of pharmacokinetics and pharmacodynamics of medications and their potential as adjuvant therapeutics. | Clin Transl Med | 2024 | 39167024 | PubTator, text mining | PubMed |
| Perfused In Vitro Intestine Tissue Model to Evaluate the Role of Stromal and Immune Cells in Epithelial Response to Inflammatory Cues and Drug Therapies. | ACS Appl Bio Mater | 2024 | 39146214 | PubTator, text mining | PubMed |
| Interplay between glypican-1, amyloid-β and tau phosphorylation in human neural stem cells. | Neuroscience | 2024 | 38992568 | PubTator, text mining | PubMed |
| Pan-cancer analysis and the oncogenic role of Glypican 1 in hepatocellular carcinoma. | Sci Rep | 2024 | 38982153 | PubTator, text mining | PubMed |
| Evaluation of antitumor potential of an anti-glypican-1 monoclonal antibody in preclinical lung cancer models reveals a distinct mechanism of action. | Explor Target Antitumor Ther | 2024 | 38966167 | PubTator, text mining | PubMed |
| Step by step analysis on gene datasets of growth phases in hematopoietic stem cells. | Biochem Biophys Rep | 2024 | 38881758 | PubTator, text mining | PubMed |
| Extracellular Vesicle Preparation and Analysis: A State-of-the-Art Review. | Adv Sci (Weinh) | 2024 | 38874129 | PubTator, text mining | PubMed |
| Antibody drug conjugate, a level-up version of monoclonal antibody? | Int J Surg | 2024 | 38833359 | PubTator, text mining | PubMed |
| Simpson-Golabi-Behmel syndrome. | Am J Med Genet C Semin Med Genet | 2024 | 38766979 | PubTator, text mining | PubMed |
| Heparan sulfate proteoglycans: Mediators of cellular and molecular Alzheimer's disease pathogenic factors via tunnelling nanotubes? | Mol Cell Neurosci | 2024 | 38750678 | PubTator, text mining | PubMed |
| Role of Hedgehog Signaling Pathways in Multipotent Mesenchymal Stem Cells Differentiation. | Cell Transplant | 2024 | 38695366 | PubTator, text mining | PubMed |
| TransGEM: a molecule generation model based on Transformer with gene expression data. | Bioinformatics | 2024 | 38632084 | PubTator, text mining | PubMed |
| Codetection of Proteins and RNAs on Extracellular Vesicles for Pancreatic Cancer Early Diagnosis. | Anal Chem | 2024 | 38626343 | PubTator, text mining | PubMed |
| Exploring Heparan Sulfate Proteoglycans as Mediators of Human Mesenchymal Stem Cell Neurogenesis. | Cell Mol Neurobiol | 2024 | 38546765 | PubTator, text mining | PubMed |
| Extracellular Vesicles: A Crucial Player in the Intestinal Microenvironment and Beyond. | Int J Mol Sci | 2024 | 38542448 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2817/papers?page=6